抗癌医药中间体

 主页 / 产品目录 / Inhibitors / EGFR inhibitor / 抗癌医药中间体
抗癌医药中间体

抗癌医药中间体

编号ABP000880 化学名称SU-6668(TSU-68)/SU6668 CAS252916-29-3 MDL: MFCD09743433 分子式C18H18N2O3 分子量310.351 纯度 >98 %

化学名称 : 抗癌医药中间体

CAS : 252916-29-3

英文名称: SU-6668(TSU-68)/SU6668

英文同义词: TSU-68

溶解度:Soluble in DMSO

储存条件:at -20℃ 2 years

生物活性

Motesanib diphosphate (AMG 706) is a novel oral inhibitor of VEGF receptors, platelet-derived growth-factor receptor, and KIT. AMG 706 potently inhibited VEGF-induced but not bFGF-induced proliferation of HUVECs with IC50 values of 10 nmol/L and >3,000 nmol/L, respectively. Similarly, AMG 706 potently inhibited both PDGFinduced proliferation and SCF-induced c-kit phosphorylation with IC50 values of 207 and 37 nmol/L, respectively. AMG 706 displayed no activity against unrelated kinases as evidenced by the lack of activity against EGF-induced EGFR phosphorylation in A431 cells (IC50, >25 Amol/L).

参考文献

1. AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts. Polverino, A., Coxon, A., et al. 2006 Cancer Research 66 (17), pp. 8715-8721

询价